open access

Vol 76, No 12 (2018)
EDITORIALS
Published online: 2018-12-17
Submitted: 2018-11-13
Accepted: 2018-11-13
Get Citation

Implantable cardioverter-defibrillator therapy in patients with congenital long QT syndrome: do we know what we need to know?

Gerold Mönnig, Virgilijus Ziaukas, Matthias Koopmann
DOI: 10.5603/KP.2018.0230
·
Pubmed: 30566214
·
Kardiol Pol 2018;76(12):1665-1667.

open access

Vol 76, No 12 (2018)
EDITORIALS
Published online: 2018-12-17
Submitted: 2018-11-13
Accepted: 2018-11-13

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Implantable cardioverter-defibrillator therapy in patients with congenital long QT syndrome: do we know what we need to know?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 12 (2018)

Pages

1665-1667

Published online

2018-12-17

DOI

10.5603/KP.2018.0230

Pubmed

30566214

Bibliographic record

Kardiol Pol 2018;76(12):1665-1667.

Authors

Gerold Mönnig
Virgilijus Ziaukas
Matthias Koopmann

References (10)
  1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
  2. Zienciuk-Krajka A, Sterliński M, Filipecki A, et al. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study. Kardiol Pol. 2018 [Epub ahead of print].
  3. Mönnig G, Köbe J, Löher A, et al. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. Heart Rhythm. 2005; 2(5): 497–504.
  4. Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation. 2010; 122(13): 1272–1282.
  5. Biton Y, Rosero S, Moss AJ, et al. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients. Europace. 2018 [Epub ahead of print].
  6. Sundström E, Jensen SM, Diamant UB, et al. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines. Scand Cardiovasc J. 2017; 51(2): 88–94.
  7. Zellerhoff S, Pistulli R, Mönnig G, et al. Atrial arrhythmias in long-QT syndrome under daily life conditions: a nested case control study. J Cardiovasc Electrophysiol. 2009; 20(4): 401–407.
  8. Kirchhof P, Eckardt L, Franz MR, et al. Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome. J Cardiovasc Electrophysiol. 2003; 14(10): 1027–1033.
  9. Boersma L, Barr C, Knops R, et al. EFFORTLESS Investigator Group. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study. J Am Coll Cardiol. 2017; 70(7): 830–841.
  10. Mönnig G, Eckardt L, Wedekind H, et al. Electrocardiographic risk stratification in families with congenital long QT syndrome. Eur Heart J. 2006; 27(17): 2074–2080.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl